Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

A the COVID-19 public health emergency continues to evolve, SNMMI issues updated guidance

News | SNMMI

SNMMI Issues Updated Statement: COVID-19 and V/Q Lung Studies

September 18, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), as a professional society ...

September 18, 2023

NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Curadh’s molecularly targeted radiation (MTR) programs for treatment of solid tumors

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and Curadh MTR Announce a Strategic Long Term Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

August 31, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

August 31, 2023

First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity

News | Radiopharmaceuticals and Tracers

First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma

August 29, 2023 — NorthStar Medical Radioisotopes, LLC (“NorthStar"), a global innovator in the development, production ...

August 29, 2023

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

News | Radiopharmaceuticals and Tracers

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a ...

August 29, 2023

Radiopharmaceutical-directed treatment ushers in a new era of autonomous radiotherapy

News | Radiation Therapy

World’s First Cancer Patient Treated with RefleXion’s Breakthrough SCINTIX Biology-guided Radiotherapy

August 23, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that the first patient has ...

August 23, 2023

Study investigated impact of radiographic media contrast shortage on stroke patient scan data

News | Contrast Media

Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

August 17, 2023

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy

News | Prostate Cancer

PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

August 15, 2023

FDA-approved generic for MRI procedures is fully substitutable for Gadavist

News | Contrast Media

Fresenius Kabi Further Expands Radiology Portfolio with Launch of Gadobutrol Injection

August 8, 2023 — Fresenius Kabi announced it has launched Gadobutrol Injection, a generic substitute for the contrast ...

August 08, 2023

News | Radiation Therapy

RayCare in Clinical Use with CyberKnife at Lausanne University Hospital (CHUV) in Switzerland

August 3, 2023 —RaySearch Laboratories AB announced that Lausanne University Hospital (CHUV), Switzerland, has treated ...

August 03, 2023

A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers.

News | Radiopharmaceuticals and Tracers

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

July 25, 2023

Positron Corporation has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft.

News | PET-CT

Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...

July 25, 2023

NorthStar’s non-carrier added (n.c.a.) Ac-225 to be used in Bayer’s radiopharmaceutical programs

News | Molecular Imaging

NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Therapeutic Radioisotope Actinium-225 (Ac-225)

July 18, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

July 18, 2023

With uMI Panorama, United Imaging Continues to Push the Envelope on Whole-Body System Performance

News | PET-CT

United Imaging Introduces Next-Generation PET/CT Systems and Integrated Molecular Technology Platform at SNMMI

July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...

July 12, 2023

NorthStar’s high purity non-carrier-added (n.c.a.) Ac-225 to be used in advancing Nucleus’ partners radioligand therapies to treat cancer

News | Molecular Imaging

NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)

July 5, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

July 05, 2023

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others at its 2023 Annual Meeting, themed “Eye on the Patient,” held in Chicago, Illinois.

News | SNMMI

SNMMI Keeps “Eye on the Patient” at 2023 Annual Meeting

June 30, 2023 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted nearly 8,000 physicians ...

June 30, 2023

News | SNMMI

Research Showing Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease Presented at SNMMI 2023

June 29, 2023 — Research presented at the 2023 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging ...

June 29, 2023

News | SNMMI

Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

June 29, 2023

News | SNMMI

Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting

June 27, 2023 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at ...

June 27, 2023

Contrast-enhanced mammography (CEM) is an emerging modality combining digital mammography with the administration of a contrast agent

News | Contrast Media

FDA approves Bayer’s Ultravist (iopromide) Injection for Contrast-enhanced Mammography

June 26, 2023 — Bayer announced that Ultravist (iopromide)-300, -370, its iodine-based contrast agent, has been approved ...

June 26, 2023

Nizar A. Mullani, one of the pioneers of the first positron emission tomography (PET) prototype, has been named as this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award.

News | SNMMI

Nizar A. Mullani Receives SNMMI 2023 Georg Charles de Hevesy Nuclear Pioneer Award

June 26, 2023 — Nizar A. Mullani, one of the pioneers of the first positron emission tomography (PET) prototype, has ...

June 26, 2023